US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist

23.860
+0.730+3.16%

Close Dec 20 16:00 ET

23.860
0.0000.00%

Post 16:20 ET

1.40BMarket Cap-15.91P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.96%-29.42M

-274.02%-62.25M

-61.86%-28.54M

-24.66%-99.91M

-71.09%-31.04M

-129.61%-34.6M

19.49%-16.64M

32.86%-17.63M

-49.20%-80.14M

5.85%-18.14M

Net income from continuing operations

-72.11%-69.03M

82.11%-38.84M

-138.07%-43.86M

-304.21%-338.79M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

-27.38%-83.82M

7.94%-18.82M

Operating gains losses

----

--214.63M

--0

--25.06M

----

Depreciation and amortization

--0

-52.52%744K

-336.56%-220K

--0

-26.89%416K

35.98%548K

-0.57%1.57M

-77.37%93K

Other non cash items

216.85%18.58M

15,500.00%624K

21,400.00%430K

236.82%2.77M

3,854.03%18.66M

-4,540.50%-15.9M

103.88%4K

-97.92%2K

814.44%823K

291.87%472K

Change In working capital

230.18%10.35M

-588.21%-29.16M

354.62%3.47M

5.40%-5.21M

-60.88%-1.86M

-803.01%-7.95M

659.70%5.97M

69.06%-1.36M

-400.22%-5.5M

23.46%-1.16M

-Change in receivables

--0

-14.77%375K

-44.56%163K

880.53%1.48M

-346.90%-1.32M

122.84%45K

153.99%440K

136.07%294K

-Change in prepaid assets

5,762.07%3.28M

-358.85%-7.11M

-161.25%-381K

383.65%3.25M

-103.78%-65K

86.94%-58K

206.89%2.75M

314.67%622K

5.92%-1.14M

407.08%1.72M

-Change in payables and accrued expense

196.18%7.07M

-649.28%-22.05M

316.52%3.85M

-103.07%-7.08M

35.70%-1.96M

-509.36%-7.35M

221.89%4.01M

48.79%-1.78M

-603.47%-3.48M

-259.69%-3.05M

-Change in other current liabilities

--0

-434.71%-2.33M

--0

-4,214.89%-2.03M

23.66%-100K

-66.39%-198K

-7.67%-435K

-16.95%-138K

-Change in other working capital

----

165.34%575K

--0

527.21%628K

93.09%-53K

-124.61%-880K

100.60%17K

Cash from discontinued investing activities

Operating cash flow

14.96%-29.42M

-274.02%-62.25M

-61.86%-28.54M

-24.66%-99.91M

-71.09%-31.04M

-129.61%-34.6M

19.49%-16.64M

32.86%-17.63M

-49.20%-80.14M

5.85%-18.14M

Investing cash flow

Cash flow from continuing investing activities

143.78%42.74M

-1,882.81%-120.52M

-691.34%-104.96M

-290.14%-108.39M

-351.94%-35.27M

-691.74%-97.63M

801.33%6.76M

-31.09%17.75M

352.04%57.01M

44.88%14M

Net PPE purchase and sale

--0

----

1,350.00%475K

--0

----

93.37%-38K

--0

Net intangibles purchase and sale

----

--15M

--0

----

--0

Net business purchase and sale

--0

----

--3.04M

--0

----

--0

Net investment purchase and sale

137.95%42.74M

-3,808.25%-120.52M

-691.34%-104.96M

-322.46%-126.9M

-351.94%-35.27M

-782.61%-112.63M

333.33%3.25M

-31.19%17.75M

358.76%57.05M

44.88%14M

Cash from discontinued investing activities

Investing cash flow

143.78%42.74M

-1,882.81%-120.52M

-691.34%-104.96M

-290.14%-108.39M

-351.94%-35.27M

-691.74%-97.63M

801.33%6.76M

-31.09%17.75M

352.04%57.01M

44.88%14M

Financing cash flow

Cash flow from continuing financing activities

201.99%12.78M

-99.83%360K

1,721,550.00%172.17M

746.05%361.08M

2,045,175.00%163.61M

-9,539.23%-12.53M

390.59%209.99M

-16.67%10K

2,963.75%42.68M

-110.00%-8K

Net issuance payments of debt

--0

96.17%-16K

--0

95.43%-8K

95.35%-8K

18.04%-418K

95.27%-8K

Net common stock issuance

---157.31M

----

294.43%169.11M

--169.11M

--0

----

--42.87M

--0

Net preferred stock issuance

1,436.26%168.85M

-180.57%-169.21M

--169.21M

--197.36M

--0

---12.64M

--210M

--0

Proceeds from stock option exercised by employees

1,155.24%1.32M

--495K

24,288.89%4.39M

82.43%405K

--282K

176.32%105K

--0

-90.22%18K

-88.33%222K

--0

Net other financing activities

---78K

--0

---1.43M

---5.79M

----

Cash from discontinued financing activities

Financing cash flow

201.99%12.78M

-99.83%360K

1,721,550.00%172.17M

746.05%361.08M

2,045,175.00%163.61M

-9,539.23%-12.53M

390.59%209.99M

-16.67%10K

2,963.75%42.68M

-110.00%-8K

Net cash flow

Beginning cash position

-80.79%45.47M

523.40%227.87M

419.59%189.22M

114.46%36.42M

126.81%91.9M

502.63%236.68M

122.00%36.55M

114.46%36.42M

-81.53%16.98M

52.89%40.52M

Current changes in cash

118.03%26.1M

-191.15%-182.41M

30,582.54%38.66M

681.77%152.77M

2,445.66%97.3M

-11,226.75%-144.76M

774.56%200.11M

125.61%126K

126.08%19.54M

56.45%-4.15M

Effect of exchange rate changes

194.12%16K

--0

-136.36%-4K

123.58%25K

-60.87%18K

70.18%-17K

118.06%13K

147.83%11K

-606.67%-106K

1,433.33%46K

End cash Position

-22.11%71.58M

-80.79%45.47M

523.40%227.87M

419.59%189.22M

126.81%91.9M

502.63%236.68M

122.00%36.55M

114.46%36.42M

Free cash flow

14.96%-29.42M

-274.02%-62.25M

-61.86%-28.54M

-24.60%-99.91M

-71.09%-31.04M

-129.59%-34.6M

19.49%-16.64M

32.95%-17.63M

-47.69%-80.18M

5.85%-18.14M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.96%-29.42M	-274.02%-62.25M	-61.86%-28.54M	-24.66%-99.91M	-71.09%-31.04M	-129.61%-34.6M	19.49%-16.64M	32.86%-17.63M	-49.20%-80.14M	5.85%-18.14M
Net income from continuing operations	-72.11%-69.03M	82.11%-38.84M	-138.07%-43.86M	-304.21%-338.79M	-235.67%-63.18M	-119.96%-40.11M	-872.45%-217.08M	24.61%-18.42M	-27.38%-83.82M	7.94%-18.82M
Operating gains losses	----	----	----	--214.63M	--0	--25.06M	----	----	----	----
Depreciation and amortization	--0	--0	--0	-52.52%744K	-336.56%-220K	--0	-26.89%416K	35.98%548K	-0.57%1.57M	-77.37%93K
Other non cash items	216.85%18.58M	15,500.00%624K	21,400.00%430K	236.82%2.77M	3,854.03%18.66M	-4,540.50%-15.9M	103.88%4K	-97.92%2K	814.44%823K	291.87%472K
Change In working capital	230.18%10.35M	-588.21%-29.16M	354.62%3.47M	5.40%-5.21M	-60.88%-1.86M	-803.01%-7.95M	659.70%5.97M	69.06%-1.36M	-400.22%-5.5M	23.46%-1.16M
-Change in receivables	--0	--0	--0	-14.77%375K	-44.56%163K	880.53%1.48M	-346.90%-1.32M	122.84%45K	153.99%440K	136.07%294K
-Change in prepaid assets	5,762.07%3.28M	-358.85%-7.11M	-161.25%-381K	383.65%3.25M	-103.78%-65K	86.94%-58K	206.89%2.75M	314.67%622K	5.92%-1.14M	407.08%1.72M
-Change in payables and accrued expense	196.18%7.07M	-649.28%-22.05M	316.52%3.85M	-103.07%-7.08M	35.70%-1.96M	-509.36%-7.35M	221.89%4.01M	48.79%-1.78M	-603.47%-3.48M	-259.69%-3.05M
-Change in other current liabilities	--0	--0	--0	-434.71%-2.33M	--0	-4,214.89%-2.03M	23.66%-100K	-66.39%-198K	-7.67%-435K	-16.95%-138K
-Change in other working capital	----	----	----	165.34%575K	--0	--0	527.21%628K	93.09%-53K	-124.61%-880K	100.60%17K
Cash from discontinued investing activities
Operating cash flow	14.96%-29.42M	-274.02%-62.25M	-61.86%-28.54M	-24.66%-99.91M	-71.09%-31.04M	-129.61%-34.6M	19.49%-16.64M	32.86%-17.63M	-49.20%-80.14M	5.85%-18.14M
Investing cash flow
Cash flow from continuing investing activities	143.78%42.74M	-1,882.81%-120.52M	-691.34%-104.96M	-290.14%-108.39M	-351.94%-35.27M	-691.74%-97.63M	801.33%6.76M	-31.09%17.75M	352.04%57.01M	44.88%14M
Net PPE purchase and sale	--0	----	----	1,350.00%475K	--0	--0	----	----	93.37%-38K	--0
Net intangibles purchase and sale	----	----	----	--15M	--0	----	----	----	--0	--0
Net business purchase and sale	--0	----	----	--3.04M	--0	--0	----	----	--0	--0
Net investment purchase and sale	137.95%42.74M	-3,808.25%-120.52M	-691.34%-104.96M	-322.46%-126.9M	-351.94%-35.27M	-782.61%-112.63M	333.33%3.25M	-31.19%17.75M	358.76%57.05M	44.88%14M
Cash from discontinued investing activities
Investing cash flow	143.78%42.74M	-1,882.81%-120.52M	-691.34%-104.96M	-290.14%-108.39M	-351.94%-35.27M	-691.74%-97.63M	801.33%6.76M	-31.09%17.75M	352.04%57.01M	44.88%14M
Financing cash flow
Cash flow from continuing financing activities	201.99%12.78M	-99.83%360K	1,721,550.00%172.17M	746.05%361.08M	2,045,175.00%163.61M	-9,539.23%-12.53M	390.59%209.99M	-16.67%10K	2,963.75%42.68M	-110.00%-8K
Net issuance payments of debt	--0	--0	--0	96.17%-16K	--0	--0	95.43%-8K	95.35%-8K	18.04%-418K	95.27%-8K
Net common stock issuance	---157.31M	----	----	294.43%169.11M	--169.11M	--0	----	----	--42.87M	--0
Net preferred stock issuance	1,436.26%168.85M	-180.57%-169.21M	--169.21M	--197.36M	--0	---12.64M	--210M	--0	--0	--0
Proceeds from stock option exercised by employees	1,155.24%1.32M	--495K	24,288.89%4.39M	82.43%405K	--282K	176.32%105K	--0	-90.22%18K	-88.33%222K	--0
Net other financing activities	---78K	--0	---1.43M	---5.79M	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	201.99%12.78M	-99.83%360K	1,721,550.00%172.17M	746.05%361.08M	2,045,175.00%163.61M	-9,539.23%-12.53M	390.59%209.99M	-16.67%10K	2,963.75%42.68M	-110.00%-8K
Net cash flow
Beginning cash position	-80.79%45.47M	523.40%227.87M	419.59%189.22M	114.46%36.42M	126.81%91.9M	502.63%236.68M	122.00%36.55M	114.46%36.42M	-81.53%16.98M	52.89%40.52M
Current changes in cash	118.03%26.1M	-191.15%-182.41M	30,582.54%38.66M	681.77%152.77M	2,445.66%97.3M	-11,226.75%-144.76M	774.56%200.11M	125.61%126K	126.08%19.54M	56.45%-4.15M
Effect of exchange rate changes	194.12%16K	--0	-136.36%-4K	123.58%25K	-60.87%18K	70.18%-17K	118.06%13K	147.83%11K	-606.67%-106K	1,433.33%46K
End cash Position	-22.11%71.58M	-80.79%45.47M	523.40%227.87M	419.59%189.22M	419.59%189.22M	126.81%91.9M	502.63%236.68M	122.00%36.55M	114.46%36.42M	114.46%36.42M
Free cash flow	14.96%-29.42M	-274.02%-62.25M	-61.86%-28.54M	-24.60%-99.91M	-71.09%-31.04M	-129.59%-34.6M	19.49%-16.64M	32.95%-17.63M	-47.69%-80.18M	5.85%-18.14M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data